- Long-term potential revealed for novel modifier gene therapy January 14, 2025
- GSK acquisition to advance potential best-in-class GI tumour treatment January 13, 2025
- AstraZeneca’s PARP inhibitor newly recommended by NICE January 10, 2025
- ePI rollout backed in new paper by pharmaceutical bodies January 9, 2025
- Could novel gel therapeutic set new standard of care in oncology? January 8, 2025
- FDA issues first recommendations on AI for drug development January 7, 2025
- Year in Review: Top Legal Developments of 2024 January 14, 2025
- The 43rd Annual J.P. Morgan Healthcare Conference Starts Today – A Who’s Who in Biologics at this Year’s Conference January 13, 2025
- Year in Review: Top Regulatory Developments of 2024 January 10, 2025
- Acuitas Sues GSK Seeking Declaratory Judgment of Invalidity and Non-Infringement of mRNA Vaccine Patents January 10, 2025
- Recent Ustekinumab and Denosumab Biosimilars Deals January 7, 2025
- Hospital evaluation of AI predictive tools for bias is inconsistent, study finds January 14, 2025
- HHS lays out strategic plan for healthcare AI January 14, 2025
- FTC releases second report slamming pharmacy benefit managers January 14, 2025
- Investors ask UnitedHealth for answers about delayed, denied care January 13, 2025
- Prospect Medical Holdings files for bankruptcy January 13, 2025
- CMS proposes Medicare Advantage payment hike in 2026 January 13, 2025
- After Steward crisis, new Massachusetts law aims to strengthen oversight of hospitals January 10, 2025
- Walgreens makes progress on turnaround in Q1, though losses grow January 10, 2025
- Why 340B Reform Could Happen in 2025 (video) January 14, 2025
- Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late! January 13, 2025
- Inflation-Adjusted U.S. Brand-Name Drug Prices Fell for the Seventh Consecutive Year as a New Era of Drug Pricing Dawns January 7, 2025
- Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes December 18, 2024
- Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun) December 13, 2024
- White Bagging Update 2024: Providers’ Pushback Preserves Buy-and-Bill (rerun) December 12, 2024
- Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (rerun) December 11, 2024